Note: results can be filtered by year and/or keyword. To filter on year, select the appropriate year from the drop down menu. To filter on keyword, enter relevant term into open box, select appropriate keyword, and click "filter".
The European Union’s (EU) free trade and research and development (R&D) policies promote excessive intellectual property (IP) protection. This approach jeopardises access to affordable, needed medicines and impedes needs-driven biomedical innovation.
Last updated 24 November 2014
Issue Brief: Achieving undetectable: what questions remain in scaling-up HIV virologic treatment monitoring?
Last updated 19 November 2014
Intro: As of 7 November 2014, there have been nearly 14,000 reported cases of Ebola virus disease in West Africa and nearly 5,000 deaths. The number of new cases is thought to currently double every three weeks. The Ebola outbreak is already a major humanitarian crisis; it is likely to turn into a disaster on a much larger scale if our collective response is not radically improved.
Last updated 12 November 2014
2014 Briefing Note The Trans-Pacific Partnership (TPP) trade deal is currently being negotiated between the US and eleven other Pacific Rim nations: Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore and Vietnam.
Last updated 13 August 2014
MSF issue brief “Pushing the envelope – does the Global Fund’s New Funding Model foster country ambitions”
Since the Global Fund to Fight AIDS, TB and Malaria (GF) cancelled its funding round in 2011, Médecins Sans Frontières (MSF), governments, and people affected by the three diseases have all called for international efforts to scale up HIV, TB and malaria programmes to be put back on track.
Last updated 12 August 2014
This issue brief is the fifth in a series produced by MSF to equip policymakers, people living with HIV/AIDS, and communities with information on the products, costs, and operational strategies to help realise scale-up of viral load monitoring, which we believe is an essential tool, along with adherence support, to help as many people on ART as possible to reach and maintain viral suppression. DOWNLOAD THE BRIEFING DOCUMENT
In many places, you can often arrive at a health centre – a place that should be buzzing with children – to find it is totally empty, no staff or anything. You understand why when you see that the fridge to store the vaccines is broken and no child has been vaccinated in months. DOWNLOAD English
Last updated 16 April 2014
The new face of an old disease: urgent action needed to tackle global drug-resistant TB threat March
Last updated 17 March 2014
Submission to the Expert Committee on “Regulation of Newer TB drugs in India”, Ministry of Health & Family Welfare, January 2014
Last updated 6 March 2014
Four essential interventions to improve HIV treatment, save lives and reduce transmission Today, nearly ten million people are receiving antiretroviral therapy (ART) in developing countries, but with an estimated additional 18 million people1 eligible for treatment, the job is far from done. With the release of new ART guidelines in 2013,2 the World Health Organization (WHO) has laid out a clear benchmark for the quality of care that national treatment programmes, treatment providers and donors should strive to achieve.
Last updated 6 December 2013